Companies · Biotechnology

Animated Dynamics, Inc.

Indianapolis · Biotechnology

Diligence memoA one-page analyst read on Animated Dynamics, Inc. — recommendation, valuation, rhythm, risks.
$3.0M
Total raised · real
2
Rounds
0.8×
Latest step-up
Top 67%
Sector rank · raised
Seed
Latest stage · inferred · Fri Mar 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Animated Dynamics, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the biotech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.80× the median modeled value of Seed Biotechnology companies in 2016–2018 (175 peers) — value vs value, same stage and era.
  • Within the normal band (80% of peer median) for its niche.
Dormant
  • Last raise 8.3 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Biotechnology

Animated Dynamics, Inc. is one of 4291 Biotechnology companies tracked from Indianapolis. By capital raised it ranks in the long tail (ahead of 34% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
4
Investors (latest)
2013
Year incorporated
2018-03-30
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeed · 2016-05-31 Raised $1.7M (real) Modeled valuation $75M (est)$1.7M$75MSeed2016Seed · 2018-03-30 Raised $1.3M (real) Modeled valuation $57M (est)$1.3M$57MSeed2018+$1.3MCumulative $3.0M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.7M · 2016
Seed extension$1.3M · 2018

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$56.7M
Base estimate est.
$919K
Conservative case
$444.5M
Upside case
$6.4M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the biotech sector profile. Directional, not a quoted figure.

Seed · modeled $75.5M · 2016-05-312016Seed · modeled $56.7M · 2018-03-302018
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
32%
Survival probability
14% low · 50% high
1.74×/yr
Annual markup
2.28×/yr upside case
6.0 yr
Elapsed time used
8.3 yr actual, capped for stale marks
biotech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
22 mo
Avg between rounds
$1.6M/yr
Capital velocity
10.1 yr
On record since
2016
First round
2
Rounds on file
How it compares to the market

Benchmarked against 4291 companies in Biotechnology. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.4× of median
This company$3.0M
Sector median$7.2M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.7× of median
This company$1.3M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 0.9× of median
This company$56.7M
Sector median$64.2M

Raised more than 34% of sector peers (real $). Modeled value above 48% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #110 of 175.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0MCapital raised (log)Kenjockety Biotechnology, LLC · Seed Raised $4.0M · modeled $177.6M (est)Mimedx Group, Inc. · Seed Raised $8.2M · modeled $177.6M (est)Helocyte, Inc. · Seed Raised $4.0M · modeled $177.5M (est)CytoDel, INC. · Seed Raised $4.1M · modeled $173.4M (est)Finch Therapeutics, Inc. · Seed Raised $4.5M · modeled $165.8M (est)Cordex Systems, Inc · Seed Raised $6.4M · modeled $164.2M (est)Viking Therapeutics, Inc. · Seed Raised $3.7M · modeled $162.3M (est)Escalier Biosciences B.V. · Seed Raised $3.5M · modeled $155.4M (est)Corino Therapeutics, Inc. · Seed Raised $3.5M · modeled $154.3M (est)BluDiagnostics, Inc. · Seed Raised $4.5M · modeled $151.0M (est)Captozyme Inc. · Seed Raised $3.4M · modeled $151.0M (est)FORGE Life Science, LLC · Seed Raised $3.6M · modeled $149.5M (est)Animated Dynamics, Inc. (this company) Raised $3.0M · modeled $56.7M (est)Animated Dynamics, Inc.
CompanyStageRaised · realValue · estvs peer med.
Kenjockety Biotechnology, LLCSeed$4.0M$177.6M2.50×
Mimedx Group, Inc.Seed$8.2M$177.6M2.50×
Helocyte, Inc.Seed$4.0M$177.5M2.50×
CytoDel, INC.Seed$4.1M$173.4M2.44×
Finch Therapeutics, Inc.Seed$4.5M$165.8M2.33×
Cordex Systems, IncSeed$6.4M$164.2M2.31×
Viking Therapeutics, Inc.Seed$3.7M$162.3M2.28×
Escalier Biosciences B.V.Seed$3.5M$155.4M2.19×
Corino Therapeutics, Inc.Seed$3.5M$154.3M2.17×
BluDiagnostics, Inc.Seed$4.5M$151.0M2.12×
Captozyme Inc.Seed$3.4M$151.0M2.12×
FORGE Life Science, LLCSeed$3.6M$149.5M2.10×
Animated Dynamics, Inc. this companySeed$3.0M$56.7M0.80×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.7M2016-05-31$8.5M$75.5M85%
Seed$1.3M2018-03-30$6.4M$56.7M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.7M2016-05-31
    • First recorded raise — entered as Seed.
    • 5 investors on this round.
  2. Seed$1.3M2018-03-30
    • Raised again after 22 mo — slower than the ~14 mo sector norm.
    • Round 1.3× smaller than the prior — bridge or down round.
    • 4 investors on this round.
Intelligence
2020 ~Q1
Modeled next raise · ~22mo cadence
$1.3M
Modeled next size est.range $1.3M$2.0M
0.8×
Last step-up
$1.6M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Travis A. Morgan2 other2018-03
David A. Nolte2018-03
David D. Nolte2016-05
John A. Turek2018-03
John J. Turek2016-05
Ted A. Schenberg2018-03
Ted J. Schenberg2016-05
Travis J. Morgan2016-05
Registry & provenance

Animated Dynamics, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1676922
SEC CIK
2013
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Sabik Medical Inc.BiotechnologySeed$3.0M$44.3Msame sector · same stage
Crossfire Medical IncBiotechnologySeed$3.0M$57.5Msame sector · same stage
Design Pharmaceuticals, Inc.BiotechnologySeed$3.0M$56.9Msame sector · same stage
Transluminal Technologies LlcBiotechnologySeed$3.0M$66.6Msame sector · same stage
Florida Biomed, LlcBiotechnologySeed$2.9M$68.8Msame sector · same stage
Antria, Inc.BiotechnologySeed$2.9M$63.9Msame sector · same stage
Azure Biotech, Inc.BiotechnologySeed$3.0M$52.3Msame sector · same stage
Asana Medical, Inc.BiotechnologySeed$2.9M$64.5Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Biological Dynamics IncBiotechnologySeries B$476.3M91%
Gi Dynamics, Inc.BiotechnologySeries B$85.7M88%
Protein Dynamics Solutions, LlcBiotechnologySeed$110.2M88%
BioDynamik, Inc.BiotechnologyPre-Seed$4.6M87%
Morphogenesis IncBiotechnologySeries B$15.1M87%
WaveFront Dynamics Inc.BiotechnologySeries A$39.6M86%
Pleural Dynamics, Inc.BiotechnologySeries A$1.7M85%
Organogenesis Holdings Inc.BiotechnologySeries D+$1.3B85%
Frequently asked
How much funding has Animated Dynamics, Inc. raised?
Animated Dynamics, Inc. has raised approximately $3.0M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Animated Dynamics, Inc.'s estimated valuation?
Provath's modeled valuation for Animated Dynamics, Inc. is approximately $56.7M (modeled range $919K–$444.5M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Animated Dynamics, Inc. at?
Animated Dynamics, Inc.'s latest modeled financing stage is Seed. Its most recent recorded round closed around Fri Mar 30.
What does Animated Dynamics, Inc. do and where is it based?
Animated Dynamics, Inc. operates in the Biotechnology sector, based in Indianapolis.
Explore related

See where Animated Dynamics, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Animated Dynamics, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.